Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: Analyses of therapeutic time window and its mechanisms

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Toyoshima, Atsuhiko ^a   Yasuhara, Takao ^a   Kameda, Masahiro ^a   Morimoto, Jun ^a   Takeuchi, Hayato ^a   Wang, Feifei ^b   Sasaki, Tatsuya ^a   Sasada, Susumu ^a   Shinko, Aiko ^a   Wakamori, Takaaki ^a   Okazaki, Mihoko ^a   Kondo, Akihiko ^a   Agari, Takashi ^a   Borlongan, Cesario V ^c   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; CHEMOKINE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; BRAIN SLICE; CELL DIFFERENTIATION; CELL LABELING; CELL MIGRATION; CELL SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT; RECANALIZATION; TRANSIENT ISCHEMIC ATTACK; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BRAIN INFARCTION; CELL MOTION; CELL TRACKING; DISEASE MODEL; ISCHEMIC ATTACK, TRANSIENT; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME FACTOR; TREATMENT OUTCOME;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INFARCTION; CELL MOVEMENT; CELL TRACKING; CHEMOKINES; DISEASE MODELS, ANIMAL; ISCHEMIC ATTACK, TRANSIENT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NERVE GROWTH FACTORS; RATS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84937019703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127302     Document Type: Article

References (44)

1. Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan CV. Stem cell transplantation for neuroprotection in stroke. Brain Sci. 2013; 3: 239-61. doi: 10.3390/brainsci3010239 PMID: 24147217
2. Yasuhara T, Borlongan CV, Date I. Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci. 2006; Jan 1; 11:760-75. PMID: 16146768
3. Ishizaka S, Horie N, Satoh K, Fukuda Y, Nishida N, Nagata I. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke. 2013; 44(3): 720-6. doi: 10.1161/STROKEAHA.112.677328 PMID: 23362081
4. Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Pinero P, Espigado I, et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke. 2012; 43(8): 2242-4. doi: 10.1161/STROKEAHA.112.659409 PMID: 22764211
5. Borlongan CV, Glover LE, Sanberg PR, Hess DC. Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy. Curr Pharm Des. 2012; 18(25): 3670-6. PMID: 22574981
6. Bao X, Wei J, Feng M, Lu S, Li G, Dou W, et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res. 2011; 7; 1367: 103-13. doi: 10.1016/j.brainres.2010.10.063 PMID: 20977892
7. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004; 35(10): 2385-9. PMID: 15345799
8. Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr, Aronowski J, et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab. 2010; 30(1): 140-9. doi: 10.1038/jcbfm.2009.198 PMID: 19773802
9. Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK. Intravascular cell replacement therapy for stroke. Neurosurg Focus. 2008; 24(3-4): E15. doi: 10.3171/FOC/2008/24/6/E13 PMID: 18518743
10. Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, Encarnacion A, et al. Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells. 2011; 29(2): 274-85. doi: 10.1002/stem.584 PMID: 21732485
11. Kameda M, Shingo T, Takahashi K, Muraoka K, Kurozumi K, Yasuhara T, et al. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur J Neurosci. 2007; 26(6): 1462-78. PMID: 17880388
12. Kamiya N, Ueda M, Igarashi H, Nishiyama Y, Suda S, Inaba T, et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 2008; 12; 83(11-12): 433-7. doi: 10.1016/j.lfs.2008.09.015 PMID: 18930067
13. Keimpema E, Fokkens MR, Nagy Z, Agoston V, Luiten PG, Nyakas C, et al. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol. 2009; 35(1): 89-102. doi: 10.1111/j.1365-2990.2008.00961.x PMID: 19187061
14. Komatsu K, Honmou O, Suzuki J, Houkin K, Hamada H, Kocsis JD. Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res. 2010; 2; 1334: 84-92. doi: 10.1016/j.brainres.2010.04.006 PMID: 20382136
15. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther. 2004; 9(2): 189-97. PMID: 14759803
16. Mitkari B, Kerkela E, Nystedt J, Korhonen M, Mikkonen V, Huhtala T, et al. Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp Neurol. 2013; 239:158-62. doi: 10.1016/j.expneurol.2012.09.018 PMID: 23059455
17. Moisan A, Pannetier N, Grillon E, Richard MJ, de Fraipont F, Remy C, et al. Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study. NMR Biomed. 2012; 25 (12): 1340-8. doi: 10.1002/nbm.2806 PMID: 22539476
18. Okuma Y, Wang F, Toyoshima A, Kameda M, Hishikawa T, Tokunaga K, et al. Mannitol enhances therapeutic effects of intra-arterial transplantation of mesenchymal stem cells into the brain after traumatic brain injury. Neurosci Lett. 2013; 25; 554: 156-61. doi: 10.1016/j.neulet.2013.08.058 PMID: 24016413
19. Shen LH, Li Y, Chen J, Zhang J, Vanguri P, Borneman J, et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience. 2006; 137(2): 393-9. PMID: 16298076
20. Shen LH, Li Y, Chen J, Cui Y, Zhang C, Kapke A, et al. One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke. 2007; 38(7): 2150-6. PMID: 17525391
21. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008; 39(5): 1569-74. doi: 10.1161/STROKEAHA.107.502047 PMID: 18323495
22. Wang F, Yasuhara T, Shingo T, Kameda M, Tajiri N, Yuan WJ, et al. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci. 2010; 26; 11:52. doi: 10.1186/1471-2202-11-52 PMID: 20420688
23. Wang LQ, Lin ZZ, Zhang HX, Shao B, Xiao L, Jiang HG, et al. Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke. CNS Neurosci Ther. 2014; 20(4): 317-26. doi: 10.1111/cns.12216 PMID: 24393245
24. Jin K, Sun Y, Xie L, Mao XO, Childs J, Peel A, et al. Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis. 2005; 18(2): 366-74. PMID: 15686965
25. Rosenblum S, Wang N, Smith TN, Pendharkar AV, Chua JY, Birk H, et al. Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke. 2012; 43(6): 1624-31. doi: 10.1161/STROKEAHA.111.637884 PMID: 22535265
26. Guzman R, De Los Angeles A, Cheshier S, Choi R, Hoang S, Liauw J, et al. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke. 2008; 39(4): 1300-6. doi: 10.1161/STROKEAHA.107.500470 PMID: 18309158
27. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res. 2010; 88(5): 1017-25. doi: 10.1002/jnr.22279 PMID: 19885863
28. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001; 32(11): 2682-8. PMID: 11692034
29. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res. 2003; 73(6): 778-86. PMID: 12949903
30. Baba T, Kameda M, Yasuhara T, Morimoto T, Kondo A, Shingo T, et al. Electrical stimulation of the cerebral cortex exerts antiapoptotic, angiogenic, and anti-inflammatory effects in ischemic stroke rats through phosphoinositide 3-kinase/Akt signaling pathway. Stroke. 2009; 40(11): e598-605. doi: 10.1161/STROKEAHA.109.563627 PMID: 19762690
31. Sato K, Kameda M, Yasuhara T, Agari T, Baba T, Wang F, et al. Neuroprotective effects of liraglutide for stroke model of rats. Int J Mol Sci. 2013; 14(11): 21513-24. doi: 10.3390/ijms141121513 PMID: 24177570
32. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002; 27; 59(4): 514-23. PMID: 12196642
33. Chua JY, Pendharkar AV, Wang N, Choi R, Andres RH, Gaeta X, et al. Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab. 2011; 31(5); 1263-71. doi: 10.1038/jcbfm.2010.213 PMID: 21157474
34. Seyfried D, Han Y, Lu D, Chen J, Bydon A, Chopp M. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg. 2004; 101(1): 104-7. PMID: 15255259
35. Seyfried DM, Han Y, Yang D, Ding J, Savant-Bhonsale S, Shukairy MS, et al. Mannitol enhances delivery of marrow stromal cells to the brain after experimental intracerebral hemorrhage. Brain Res. 2008; 11; 1224: 12-9. doi: 10.1016/j.brainres.2008.05.080 PMID: 18573239
36. Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012; 25; 79(13 Suppl 1): S52-7. PMID: 23008413
37. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004; 35(11 Suppl 1): 2659-61. PMID: 15472105
38. Fujiwara K, Date I, Shingo T, Yoshida H, Kobayashi K, Takeuchi A, et al. Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg. 2003; 99(6): 1053-62. PMID: 14705734
39. Haribabu B, Richardson RM, Fisher I, Sozzani S, Peiper SC, Horuk R, et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J Biol Chem. 1997; 272(45): 28726-31. PMID: 9353342
40. Shyu WC, Lin SZ, Yen PS, Su CY, Chen DC, Wang HJ, et al. Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J Pharmacol Exp Ther. 2008; 324(2): 834-49. PMID: 18029549
41. Wang Y, Deng Y, Zhou GQ. SDF-1alpha / CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008 Feb 21; 1195:104-12. doi: 10.1016/j.brainres.2007.11.068 PMID: 18206136
42. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, Goldenberg RC, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med. 2011; 6(1): 45-52. doi: 10.2217/rme.10.97 PMID: 21175286
43. Friedrich MA, Martins MP, Araujo MD, Klamt C, Vedolin L, Garicochea B, et al. Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke. Cell Transplant. 2012; 21 Suppl 1:S13-21. doi: 10.3727/096368912X612512 PMID: 22507676
44. Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr, Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011; 70(1): 59-69. doi: 10.1002/ana.22458 PMID: 21786299